China Resources Pharmaceutical Group Ltd.

China Resources Pharmaceutical Group Ltd.

0.52
EUR
0.00
(0.00%)
3.03BMarket Cap
Mar 24Next Earn

Total Valuation

EUR

As of June 30, 2026, China Resources Pharmaceutical Group Ltd. carries a market capitalization of 3.03B, placing it among publicly traded companies globally. Its enterprise value stands at 18.32B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.03B
Enterprise Value18.32B

Important Dates

China Resources Pharmaceutical Group Ltd.'s next confirmed earnings release is scheduled for March 24, 2027.

Earnings Date3/24/2027

Share Statistics

As of June 30, 2026, China Resources Pharmaceutical Group Ltd. has 6.28B shares outstanding.

Shares Outstanding6.28B

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio0.44
P/TBV Ratio1.35

Financial Position

As of June 30, 2026, China Resources Pharmaceutical Group Ltd. maintains a current ratio of 1.43, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

Current Ratio1.43
Quick Ratio0.18
Debt / Equity65.78

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count85,600.00

Stock Price Statistics

EUR

As of the close on November 17, 2026, China Resources Pharmaceutical Group Ltd.'s stock has declined approximately 3.70% over the past 52 weeks. The 50-day moving average sits at 0.50, while the 200-day moving average is 0.53.

52-Week Price Change-3.70%
50-Day Moving Average0.50
200-Day Moving Average0.53

Balance Sheet

EUR

As of June 30, 2026, China Resources Pharmaceutical Group Ltd. holds 3.42B in cash and equivalents against 10.13B in total debt, resulting in a net debt position of 7.97B. Total book value stands at 6.81B, with working capital of 8.11B providing operational flexibility.

Cash & Cash Equivalents3.42B
Total Debt10.13B
Net Debt7.97B
Equity (Book Value)6.81B
Book Value Per Share1.08
Working Capital8.11B